CanSino Biologics A Aktie
66,06
CNY
+4,12
CNY
+6,65
%
SHA
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 5 | 3 | 1 | 136,69 GBP | +36,36% |
| BioNTech (ADRs) | 3 | 2 | 0 | 138,40 USD | +30,09% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 1 | 1 | 80,00 USD | +112,94% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 109,86 EUR | +21,07% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |